EFPIA Pipeline
Review 2024
One of the key priorities of our Association is the production and co-design of evidence-based health and medicine policies.
In this context, we collaborate with various national and international bodies, academic institutions and other scientific bodies to conduct studies and analyses, thus contributing to the substantial institutional dialogue for the formulation of a patient-centered and sustainable pharmaceutical policy with growth potential.